Article
Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.
Oncogene - 26 Oct 2017
Huskova H, Ardin M, Weninger A, Vargova K, Barrin S, Villar S, Olivier M, Stopka T, Herceg Z, Hollstein M, Zavadil J, Korenjak M
Abstract excerpt
The information on candidate cancer driver alterations available from public databases is often descriptive and of limited mechanistic insight, which poses difficulties for reliable distinction between true driver and passenger events. To address this challenge, we performed in-depth analysis of whole-exome sequencing data from cell lines generated by a barrier bypass-clonal expansion (BBCE) protocol. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.